This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
has gotten investors even more bullish about the stock and its long-term prospects. It has been reducing the scale of its operations to become leaner, while also focusing on the medicinal market -- which would likely be legalized before the recreational market. Legalization in the U.S. million Canadian dollars.
One thing you should know off the bat is that marijuana legalization isn't inevitable in the U.S., Unlike Tilray's Irwin Simon and Canopy's David Klein, who are often on investing shows talking up their growth prospects, odds are you probably haven't even seen Bachtell or heard of him. They're also burning through tons of cash.
This is why many cannabis companies focus on their adjusted earnings before interest, taxes, depreciation, and amortization ( EBITDA ) numbers. There are some encouraging opportunities, such as in Germany, where the country recently legalized cannabis for personal use. million Canadian dollars ($1.4 once they open up.
It recently added more fuel to its growth engine by making a $2 billion acquisition that will supply it with incremental cash flow while enhancing its growth prospects. The company is paying about 10 times estimated 2024 earnings before interest, taxes, depreciation, and amortization ( EBITDA ) for these assets. billion to $6.8
Aurora reported an adjusted earnings before interest, taxes, depreciation, and amortization ( EBITDA ) profit of CA$3.4 But with cannabis investors losing heavily on pot stocks in recent years and no progress on marijuana legalization in the U.S., legalization efforts. million last quarter. the optimism has faded.
Its core EPS, which excludes costs related to the amortization of intangibles, impairments, legal settlements, and restructuring charges, fell 8% to $1.98. Several pharma stocks offer better growth prospects, more attractive valuations, and higher dividend yields than AstraZeneca does. Is AstraZeneca stock a buy?
It also reported a record adjusted earnings before interests, taxes, depreciation, and amortization ( EBITDA ) of CA$3.4 Aurora's prospects are uncertain One of the reasons behind Aurora Cannabis's poor results in recent years is that the recreational cannabis market in Canada has been a mess. Its revenue of 63.4
Several more states have legalized mobile gambling, and sports betting in particular. While it still provides a variety of fantasy sports offerings, it also operates a conventional sportsbook where legally allowed. And it's legally allowed in plenty more places than it was just a few years back. Not a lot, actually.
Tilray now sees adjusted earnings before interest, taxes, depreciaition, and amortization ( EBITDA ) of $60 million to $63 million (versus previous guidance for $68 million to $78 million), and management no longer expects to achieve positive free cash flow this year as previously anticipated.
DraftKings is gaining access to new markets as more governments move to legalize betting on sports. With the prospect of higher tax revenue likely to eventually lure the remaining state legislatures to legalize sports gambling, DraftKings has plenty of room for further expansion within the United States.
Particularly encouraging are the consecutive quarters of positive adjusted earnings before interest, taxes, depreciation, and amortization ( EBITDA ) , reaching $194 million in Q2. A looming regulation battle We can't talk about Coinbase without discussing the company's legal battle with the Securities and Exchange Commission (SEC).
legal cannabis market at $28.9 That's good news for prospective investors, though, as the dividend yield has risen past 9%. Cannabis legalization is sweeping over North America – 19 states plus Washington, D.C., Investment bank Cowen puts the U.S. billion in 2023, climbing to $36.3 billion by 2026. Revenue of $76.5
Cresco Labs Cannabis stocks have somewhat fallen out of favor lately over concerns about the lack of progress toward federal legalization in the U.S., but some still have enormous long-term potential even if legalization never comes. One factor that pressured revenue was a 5.6%
The company has achieved positive adjusted earnings before interest, taxes, depreciation and amortization ( EBITDA ) for three straight quarters. Aurora's focus, however, remains predominantly on the medical marijuana market, where growth prospects aren't nearly as promising as in the recreational market.
Both have grabbed plenty of headlines in recent years, both have failed to keep pace with the market in 2023, and neither seems to have strong prospects. Aurora Cannabis Aurora Cannabis has consistently been one of the most talked-about stocks in the Canadian pot market since recreational adult use became legal some five years ago.
It has been almost five years since Canada first legalized marijuana for recreational use. On Monday the stock closed at $0.863, as it faces the prospect of another reverse stock split in its future. Unfortunately, to say that things haven't gone well for Aurora -- or many other Canadian producers -- would be a huge understatement.
Very few public companies offer monthly dividends, and the ones that do are typically real estate investment trusts (REITs) because they are legally required to pay out 90% of their taxable earnings to shareholders. Prospects look promising for LTC Properties because America's aging population should keep demand for its services high.
And there has been some reform happening in Germany of late, which has Tilray bullish on both its near and long-term growth prospects in that market. It won't legalize marijuana for recreational use, but it will result in cannabis no longer being a prohibited substance, making it easier for doctors to prescribe it for medicinal purposes.
in the prior-year quarter, driven by operational improvements as well as lower inventory step-up amortization. The fourth quarter of 2024 was the last quarter in which we incurred step-up amortization related to the NuVasive merger. Adjusted gross profit, which excludes the impact of step-up amortization, was 67.1% versus 55.4%
Using EBITDA Multiples to Understand Your Valuation EBITDA represents your earnings before interest, taxes, depreciation, and amortization. This metric offers potential buyers a clear snapshot of your businesss core profitability, free from the effects of taxes, financing, and non-operational factors.
million, the majority of which includes a customer list asset valued at just over $20 million that will be amortized over 18 years, and we also booked goodwill of $11.8 And how are trials going with larger prospective customers? Laura Guest Scheland -- Chief Legal Officer and General Manager, Consumer Products Division Yes.
We spent the last decade applying proprietary AI expertise to structure, normalize, analyze, and digitize vast amounts of regulatory, legal, macroeconomic, and geopolitical information and to embed workflows that make data useful and actionable for our customers. The context of this Co-pilot program is evident.
million, compared to a depreciation and amortization expense of 8.9 That depreciation and amortization expense represents 57% of capital invested. And we're excited about the prospects of gaining business with them and, as I said, in growing that business. Year to date, we've made capital investments of 15.5
Do you have to reduce rev rec, will opex rise on increased legal costs? If you -- I know it's tricky to talk about legal things, but if you can shed any light on that, I'm sure it would be helpful. Rene Haas -- Chief Executive Officer Sure. So, I'll address what I can as it is an ongoing litigation. But again, hard to say.
The Compass reverse prospecting tool is a powerful new tool that enables agents and their homeowners to identify which of the 33,000 Compass agents and their millions of buyers have viewed, shared, favorited or commented on their listing. Legal pressure continues to mount on private party litigation. million in Q3 of last year.
Operator instructions] I would like to pass the conference over to our host, Adam Vandervoort, chief legal officer, Teladoc. Adam Vandervoort -- Chief Legal Officer Thank you and good afternoon. The breadth of our product portfolio continues to drive productive conversations with both prospective and existing clients.
In 2023, we prepaid over $24 million of principal ahead of our required amortization schedule, keeping us 12 months ahead of our required debt repayment schedule. I'm excited about the prospects ahead of us, and as always, I look forward to updating you on the progress throughout the year. million and $508.8 Is that right?
Before we begin, I would like to remind everyone that some of the remarks that we will make today about the company's expectations, plans, and future prospects are considered forward-looking statements under the safe harbor provision of the Private Securities Litigation Reform Act of 1995. million reversal of a legal accrual.
Total noteworthy items in the quarter were $90 million, the majority of which related to our restructuring actions partly offset by a $58 million gain related to a legal settlement. We do provide amortization and other information that allows you to stack us up against other companies, but we don't plan to change how we report at this point.
As discussed on previous calls, we expect deepwater prospects to become an even more important source of the word for the next several years, and we're not alone in this expectation. I mean, we do have the discipline of debt associated with the third financings, the regular amortizations. Kurt Hallead -- Analyst Awesome.
Interest expense, net of interest income between $20 million and $25 million, depreciation and amortization between $45 million and $50 million, stock-based compensation, which we show as a reconciling item from GAAP to non-GAAP EBITDA to be approximately $50 million. So, we're not counting on those prospectively.
With over 33,000 agents across the United States, we are able to build upon our technology differentiation and continue to invest by amortizing the cost of our investments over more agents. million prospective agents can grow their business and improve their quality of life by joining Compass. Let me share how we're going to get there.
I'll ask to note here is that our GAAP-based results are in a book loss primarily due to the extent of non-cash charges, such as depreciation and amortization tied to the accounting for acquisitions and our facility build-outs as well as stock-based compensation charges. Now getting to our financial expectations for 2024 on Slide 24.
sports betting market legalized in 2018, Sportradar supported building up their online betting product. I've spent much of my career interacting with the investment community and look forward to connecting with each of you over the next few months to further discuss our business and its multifaceted prospects. When the U.S.
We have also seen additional prospects reach out to mobilize due to challenges with their current direction, whether that was fully in-house development or collaboration with our competitors. We continue to make steady progress with more mature prospects. We also exclude stock-based compensation.
This year, through the co-pilot program, we will launch a constellation of AI agents that include quick applications catered to our individual customer personas that automate the day-to-day work of creating legislation, drafting regulatory and legal analysis, advocacy outreach, and constituent communications or regulatory responses.
Understanding how prospective buyers determine your business’s value is a key factor in a successful sale. Let’s start by defining the terms: Your EBITDA is your earnings before interest, taxes, depreciation, and amortization.
CONFIRM is a prospective multicenter study evaluating outcomes from the integrated Ion endoluminal system and mobile cone beam CT in the biopsy of pulmonary nodules, less than two centimeters in size, 155 patients from six centers throughout the U.S. were enrolled. We ended Q3 with cash and investments of $8.3 billion, higher than the $7.7
As we enter the back half of '23, we remain bullish on our full-year prospects and believe we are well-positioned to achieve continued overall record revenues for the full year. Depreciation and amortization expense increased to $1 million for the three months ended June 30, 2023, versus $0.4 million in the prior year's period.
Excluding after-tax intangible asset amortization expense and special items for both periods, adjusted net earnings for the quarter were $7.4 I'll start with Stelara, and then see if Erik can add anything from a legal perspective, and then we'll turn it over to Joaquin for your question on the Mariposa study. a year ago.
Rob Lister, chief legal officer, is also joining us today. So how much of the cost could you amortize through the local language network? So one thing I'll certainly say is I feel better about our growth prospects than exhibition's growth prospects irrespective of when the strike settles. Operator Thank you.
Before we begin, I would like to remind everyone that some of the remarks that we will make today about the company's expectations, plans, and future prospects are considered forward-looking statements under the safe harbor provision of the Private Securities Litigation Reform Act of 1995. legal reserve we took in the first quarter.
Before we begin, I would like to remind everyone that some of the remarks that we will make today are about the company's expectations, plans and future prospects and are considered forward-looking statements under the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. legal reserve we took in the first quarter.
Non-GAAP gross margin, excluding the amortization of acquired intangibles, was 75%. So we feel good about the long-term prospects there. Growth was 7%, excluding the prostate business sale and foreign exchange. COVID testing revenue decreased 84% to $2 million. Second quarter GAAP gross margin was 71%. GAAP net loss was $81 million.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content